Open AccessOrganoprotecive effects of angiotensin II receptor blockers in patients with type 2 diabetes mellitus
Author(s) -
Ivona Yanovna Yarek-Martynova,
Минара Шамхаловна Шамхалова
Publication year - 2010
Publication title -
saharnyj diabet
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.155
H-Index - 12
eISSN - 2072-0378
pISSN - 2072-0351
DOI - 10.14341/2072-0351-5675
Subject(s) - medicine , tolerability , diabetes mellitus , myocardial infarction , cardiology , angiotensin receptor blockers , ventricle , type 2 diabetes mellitus , stroke (engine) , angiotensin ii , angiotensin converting enzyme , endocrinology , receptor , blood pressure , adverse effect , mechanical engineering , engineering
High prevalence of arterial hypertension and related cardiovascular complications dictates the necessity of preparations possessed of markedorganoprotective activity and good tolerability. The currently available data suggest advantages of iACE and ARB as preparations for the treatmentof cardiovascular diseases such as ability of iACE to improve clinical picture and outcome of therapy of cardiac insufficiency, left ventricle dysfunction,and myocardial infarction. Large-scale prospective studies demonstrated effectiveness of these agents in the treatment of CHD, stroke, diabetes, renalpathology and revealed their additional advantages attributable to inhibition of angiotensin II secretion other than those related to reduction of AP.These studies gave evidence of a more pronounced decrease in the frequency of cardiovascular events under effect of ARB in high-risk patients. However,protective action of ARB on the cardiovascular system compared with that of iACE and combination of ARB+iACE awaits an in-depth study.